These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17712420)

  • 1. Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B.
    Heldermon CD; Hennig AK; Ohlemiller KK; Ogilvie JM; Herzog ED; Breidenbach A; Vogler C; Wozniak DF; Sands MS
    PLoS One; 2007 Aug; 2(8):e772. PubMed ID: 17712420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency.
    Lotfi P; Tse DY; Di Ronza A; Seymour ML; Martano G; Cooper JD; Pereira FA; Passafaro M; Wu SM; Sardiello M
    Autophagy; 2018; 14(8):1419-1434. PubMed ID: 29916295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice.
    Heldermon CD; Qin EY; Ohlemiller KK; Herzog ED; Brown JR; Vogler C; Hou W; Orrock JL; Crawford BE; Sands MS
    Gene Ther; 2013 Sep; 20(9):913-21. PubMed ID: 23535899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice.
    Mohammed EE; Snella EM; Rutz-Mendicino MM; Echevarria FD; Awedikian R; Whitley EM; Ellinwood NM
    Mol Genet Metab; 2012 Sep; 107(1-2):129-35. PubMed ID: 22867887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs.
    Ellinwood NM; Wang P; Skeen T; Sharp NJ; Cesta M; Decker S; Edwards NJ; Bublot I; Thompson JN; Bush W; Hardam E; Haskins ME; Giger U
    J Inherit Metab Dis; 2003; 26(5):489-504. PubMed ID: 14518829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological and Histological Characterization of Rod-Cone Retinal Degeneration and Microglia Activation in a Mouse Model of Mucopolysaccharidosis Type IIIB.
    Tse DY; Lotfi P; Simons DL; Sardiello M; Wu SM
    Sci Rep; 2015 Nov; 5():17143. PubMed ID: 26607664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system pathology in preclinical MPS IIIB dogs reveals progressive changes in clinically relevant brain regions.
    Egeland MT; Tarczyluk-Wells MM; Asmar MM; Adintori EG; Lawrence R; Snella EM; Jens JK; Crawford BE; Wait JCM; McCullagh E; Pinkstaff J; Cooper JD; Ellinwood NM
    Sci Rep; 2020 Nov; 10(1):20365. PubMed ID: 33230178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIB.
    Canal MM; Wilkinson FL; Cooper JD; Wraith JE; Wynn R; Bigger BW
    Behav Brain Res; 2010 Jun; 209(2):212-20. PubMed ID: 20138090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain.
    Gografe SI; Garbuzova-Davis S; Willing AE; Haas K; Chamizo W; Sanberg PR
    Comp Med; 2003 Dec; 53(6):622-32. PubMed ID: 14727810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice.
    Ashby FJ; Castillo EJ; Ludwig Y; Andraka NK; Chen C; Jamieson JC; Kabbej N; Sommerville JD; Aguirre JI; Heldermon CD
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery.
    Fu H; DiRosario J; Kang L; Muenzer J; McCarty DM
    J Gene Med; 2010 Jul; 12(7):624-33. PubMed ID: 20603889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome.
    Kan SH; Elsharkawi I; Le SQ; Prill H; Mangini L; Cooper JD; Lawrence R; Sands MS; Crawford BE; Dickson PI
    Mol Genet Metab; 2021 Jun; 133(2):185-192. PubMed ID: 33839004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum.
    Cressant A; Desmaris N; Verot L; Bréjot T; Froissart R; Vanier MT; Maire I; Heard JM
    J Neurosci; 2004 Nov; 24(45):10229-39. PubMed ID: 15537895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine cellular model of mucopolysaccharidosis, type IIIB (MPS IIIB) - A preliminary study with particular emphasis on the non-oxidative l-cysteine metabolism.
    Kaczor-Kamińska M; Stalińska K; Kamiński K; Pisarek A; Maziarz U; Feldman A; Wróbel M
    Biochimie; 2020 Jul; 174():84-94. PubMed ID: 32335228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA).
    Hemsley KM; Hopwood JJ
    Behav Brain Res; 2005 Mar; 158(2):191-9. PubMed ID: 15698885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease correction in mucopolysaccharidosis type IIIB mice by intraparenchymal or cisternal delivery of a capsid modified AAV8 codon-optimized NAGLU vector.
    Rouse CJ; Hawkins K; Kabbej N; Dalugdug J; Kunta A; Kim MJ; Someya S; Herbst Z; Gelb M; Dinelli I; Butterworth E; Falk DJ; Rosenkrantz E; Elmohd H; Khaledi H; Mowafy S; Ashby F; Heldermon CD
    Hum Mol Genet; 2023 Jan; 32(3):417-430. PubMed ID: 35997776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B.
    Garbuzova-Davis S; Klasko SK; Sanberg PR
    J Comp Neurol; 2009 Jul; 515(1):93-101. PubMed ID: 19399896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure.
    Schiattarella GG; Cerulo G; De Pasquale V; Cocchiaro P; Paciello O; Avallone L; Belfiore MP; Iacobellis F; Di Napoli D; Magliulo F; Perrino C; Trimarco B; Esposito G; Di Natale P; Pavone LM
    PLoS One; 2015; 10(7):e0131662. PubMed ID: 26147524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB.
    Ellinwood NM; Valentine BN; Hess AS; Jens JK; Snella EM; Jamil M; Hostetter SJ; Jeffery ND; Smith JD; Millman ST; Parsons RL; Butt MT; Chandra S; Egeland MT; Assis AB; Nelvagal HR; Cooper JD; Nestrasil I; Mueller BA; Labounek R; Paulson A; Prill H; Liu XY; Zhou H; Lawrence R; Crawford BE; Grover A; Cherala G; Melton AC; Cherukuri A; Vuillemenot BR; Wait JCM; O'Neill CA; Pinkstaff J; Kovalchin J; Zanelli E; McCullagh E
    J Pharmacol Exp Ther; 2022 Sep; 382(3):277-286. PubMed ID: 35717448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pathologic findings associated with urinary retention in a mouse model of mucopolysaccharidosis type IIIB.
    Gografe SI; Sanberg PR; Chamizo W; Monforte H; Garbuzova-Davis S
    Comp Med; 2009 Apr; 59(2):139-46. PubMed ID: 19389305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.